Table 3.
Characteristic of studied group with ALS-FRSr and Norris scale results. Tx: transplantation.
| Parameter | ALS Patients (n = 18) |
|
|---|---|---|
| Age (mean ± SD, years) | 53.11 ± 11.14 | |
| Sex (male/female) | 9/9 | |
| Disease onset (bulbar/spinal) | 2/16 | |
| Age at disease onset (mean ± SD, years) | 50.00 ± 12.95 | |
| Symptom duration (mean ± SD, months) | 37.39 ± 34.93 | |
| Bone marrow volume (mean ± SD, mL) | 109.78 ± 21.37 | |
| Number of mononuclear cells (mean ± SD) | 200 x 106 ± 95.8 | |
| Number of administered Lin− cells (mean ± SD) | 5.49 x 106 ± 4.40 | |
| ALS-FRSr score (mean ± SD) | Before Lin− Tx | 29.17 ± 5.92 |
| 3 days after Lin− Tx | 29.17 ± 5.92 | |
| 5 days after Lin− Tx | 29.17 ± 5.92 | |
| 7 days after Lin− Tx | 29.17 ± 5.92 | |
| 28 days after Lin− Tx | 29.75 ± 6.44 | |
| Norris scale score (mean ± SD) | Before Lin− Tx | 80.38 ± 17.49 |
| 3 days after Lin− Tx | 82.83 ± 18.28 | |
| 5 days after Lin− Tx | 82.89 ± 18.34 | |
| 7 days after Lin− Tx | 82.89 ± 18.34 | |
| 28 days after Lin− Tx | 86.63 ± 17.30 | |